NMDA receptor hypofunction produces concomitant firing rate potentiation burst activity reduction in the prefrontal cortex

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 22, 2004, Pages 8467-8472

  Jackson, Mark E ^a   Homayoun, Houman ^a   Moghaddam, Bita ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FRONTAL LOBE; GENETIC LINKAGE; MALE; MEMORY DISORDER; NEUROPHARMACOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SCHIZOPHRENIA; SPIKE WAVE; STEREOTYPY; WORKING MEMORY;

ACTION POTENTIALS; ANIMALS; BEHAVIOR; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MALE; NEURONS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 2942537881     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0308455101     Document Type: Article

References (51)

1. Harrison, P. J. & Owen, M. J. (2003) Lancet 361, 417-419.
2. Moghaddam, B. (2003) Neuron 40, 881-884.
3. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., Heninger, G. R., Bowers, M., Jr., & Charney, D. S. (1994) Arch. Gen. Psychiatry 51, 199-214.
4. Lahti, A. C., Koffel, B., LaPorte, D. & Tamminga, C. A. (1995) Neuropsychopharmacology 13, 9-19.
5. Newcomer, J. W., Farber, N. B., Jevtovic-Todorovic, V., Selke, G., Melson, A. K., Hershey, T., Craft, S. & Olney, J. W. (1999) Neuropsychopharmacology 20, 106-118.
6. Adler, C. M., Goldberg, T. E., Malhotra, A. K., Pickar, D. & Breier, A. (1998) Biol. Psychiatry 43, 811-816.
7. Konradi, C. & Heckers, S. (2003) Pharmacol. Ther. 97, 153-179.
8. Goff, D. C. & Coyle, J. T. (2001) Am. J. Psychiatry 158, 1367-1377.
9. Geyer, M. & Moghaddam, B. (2002) in Psychopharmacology: The Fifth Generation of Progress, eds. Davis, K. L., Charney, C., Coyle, J. T. & Nemeroff, C. (Lippincott Williams and Wilkins, Philadelphia), pp. 689-702.
10. Olney, J. & Farber, N. (1995) Arch. Gen. Psychiatry 52, 998-1007.
11. Lahti, A. C., Holocomb, H. H., Medoff, D. R. & Tammings, C. A. (1995) NeuroReport 6, 869-872.
12. Breier, A., Malhotra, A. K., Pinals, D. A., Weisenfeld, N. I. & Pickar, D. (1997) Am. J. Psychiatry 154, 805-811.
13. Jentsch, J. D. & Roth, R. H. (1999) Neuropsychopharmacology 20, 201-225.
14. Takahata, R. & Moghaddam, B. (2003) Neuropsychopharmacology 28, 1117-1124.
15. Goldman-Rakic, P. (1999) Biol. Psychiatry 46, 650-661.
16. Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F. & Goldberg, T. E. (2001) Biol. Psychiatry 50, 825-844.
17. Robbins, T. (1996) Philos. Trans. R. Soc. London B 351, 1463-1470.
18. Goldman-Rakic, P. (1995) Neuron 14, 477-485.
19. Steinpreis, R. (1996) Behav. Brain Res. 74, 45-55.
20. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates (Academic, San Diego).
21. McCormick, D. A., Connors, B. W., Lighthall, J. W. & Prince, D. A. (1985) J. Neurophysiol 54, 782-806.
22. Jung, M., Qin, Y., McNaughton, B. & Barnes, C. (1998) Cereb. Cortex 8, 437-450.
23. Baeg, E. H., Kim, Y. B., Jang, J., Kim, H. T., Mook-Jung, I. & Jung, M. W. (2001) Cereb. Cortex 11, 441-451.
24. Connors, B. W. & Gutnick, M. J. (1990) Trends Neurosci. 13, 99-104.
25. Legendy, C. R. & Salcman, M. (1985) J. Neurophysiol. 53, 926-939.
26. Ragozzino, M. E., Unick, K. E. & Gold, P. E. (1996) Proc. Natl. Acad. Sci. USA 93, 4693-4698.
27. Javitt, D. C. & Zukin, S. R. (1991) Am. J. Psychiatr. 148, 1301-1308.
28. O'Donnell, P. & Grace, A. A. (1995) J. Neurosci. 15, 3622-3639.
29. Miller, E. K. & Cohen, J. D. (2001) Annu. Rev. Neurosci. 24, 167-202.
30. Cooper, D. C. (2002) Neurochem. Int. 41, 333-340.
31. Lisman, J. E. (1997) Trends Neurosci. 20, 38-43.
32. Gratton, A., Hoffer, B. J. & Freedman, R. (1987) Neuropharmacology 26, 1275-1283.
33. Moghaddam, B., Adams, B., Verma, A. & Daly, D. (1997) J. Neurosci. 17, 2921-2927.
34. Moghaddam, B. & Adams, B. (1998) Science 281, 1349-1352.
35. Lorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J. & Varney, M. A. (2003) Neuroscience 117, 697-706.
36. Greene, R. (2001) Hippocampus 11, 569-577.
37. Abel, K. M., Allin, M. P., Kucharska-Pietura, K., David, A., Andrew, C., Williams, S., Brammer, M. J. & Phillips, M. L. (2003) NeuroReport 14, 387-389.
38. Kobayashi, T., Nagao, T., Fukuda, H., Hicks, T. P. & Oka, J. I. (1993) NeuroReport 4, 735-738.
39. Grubb, B. D., Riley, R. C., Hope, P. J., Pubols, L. & Duggan, A. W. (1996) Neuroscience 74, 1077-1086.
40. Poulain, P. (2001) Eur. J. Neurosci. 14, 657-665.
41. Harsch, A. & Robinson, H. P. (2000) J. Neurosci. 20, 6181-6192.
42. Shi, W. X. & Zhang, X. X. (2003) J. Pharmacol. Exp. Ther. 305, 680-687.
43. Eggermont, J. J., Smith, G. M. & Bowman, D. (1993) J. Neurophysiot. 69, 1292-1313.
44. Bair, W., Koch, C., Newsome, W. & Britten, K. (1994) J. Neurosci. 14, 2870-2892.
45. Friedman, A. & Gutnick, M. J. (1987) Neurosci. Lett. 81, 117-122.
46. Steriade, M., Amzica, F. & Contreras, D. (1994) Electroencephalogr. Clin. Neurophysiol. 90, 1-16.
47. Lisman, J., Fellous, J. & Wang, X. (1998) Nat. Neurosci. 1, 273-275.
48. Schultz, W. & Dickinson, A. (2000) Annu. Rev. Neurosci. 23, 473-500.
49. Valentine, P. A. & Eggermont, J. J. (2001) Hearing Res. 154, 146-157.
50. Kaneoke, Y. & Vitek, J. L. (1996) J. Neurosci. Methods 68, 211-223.
51. Scarpini, E., Scheltens, P. & Feldman, H. (2003) Lancet Neurol. 2, 539-547.